|
Explore your potential with a career at Forest
At Forest we believe in the power of potential. We credit our success
to hiring and developing talented, committed people and providing an
environment where diversity is embraced and potential can be fulfilled.
Forest develops,
manufactures and sells branded and generic forms of ethical products
requiring a physician’s prescription, which are used for the treatment
of a wide range of illnesses, such as depression, anxiety, Alzheimer’s
disease, hypertension and alcohol dependence.
Forest is also...
- Consistently ranked as one of the "50 Best Companies to Sell
For" by Selling Power magazine
- A Top Four Pharma Company three consecutive years (Pharmaceutical Executive Industry Audit, September 2005, 2006, 2007)
- One of the Top 15 U.S. Pharma Companies, and among the top 50
globally (Pharmaceutical Executive, May 2007)
People depend on
our products. We depend on our people.
At Forest, we encourage and support teamwork at every level throughout
our Company while valuing individual commitment, energy and creativity.
We are highly entrepreneurial, clearly seeing and vigorously pursuing
our goals of helping people: the physicians and patients who prescribe
and use our products, the communities in which we work and reside and
the employees who move our business forward with talent, commitment
and integrity.
Hard work pays off.
We encourage personal well-being and professional growth so our employees
can achieve a healthy work/life balance. We reward success with challenging
work, highly competitive salaries, progressive benefits and incentives,
including an opportunity to share in the Company’s equity growth
and a paid day off when you get married.
While
our product pipeline competes with those of larger pharmaceutical companies,
because of our size, our employees tend to have deeper involvement and
advance faster than they would elsewhere in the industry. Every employee
in every capacity throughout our company makes a difference.
About Forest
Our products are marketed principally in the United States and Europe.
Our primary therapeutic markets include CNS disorders, cardiovascular,
respiratory and endocrinology. Forest is developing additional compounds
in these and other areas. Our principal marketed products include:
- Lexapro® (escitalopram
oxalate) for the treatment of depression and General Anxiety Disorder
(GAD)
- Namenda® (memantine
HCl) for the treatment of moderate to severe Alzheimer’s disease
- Benicar® (olmesartan
medoxomil) and Benicar HCT™ (olmesartan medoxomil hydrochlorothiazide)
for the treatment of hypertension (co-marketed with Sankyo Pharma)
- Campral® (acamprosate
calcium) for the treatment of alcohol dependence
In the United States, Forest’s
branded pharmaceutical products are marketed directly by the Company's
Forest Pharmaceuticals subsidiary. The Company’s generic products
are marketed directly by its Inwood Laboratories, Inc. subsidiary. In
the United Kingdom, Ireland and certain export markets, Forest products
are marketed by the Company's Forest Laboratories European subsidiary.
Forest Laboratories common stock is traded on the New York Stock Exchange;
the trading symbol is FRX.
Based in New York City, with operations in the New York metropolitan area, Missouri, Ohio, California, Ireland and the U.K., Forest currently employs 5,000 people, including a national, professionally-trained sales force.
To learn more about Forest and our career opportunities, please visit:
www.frx.com.
View Jobs for Forest Laboratories, Inc. |
